Stung by the Pope and Health Studies, Congress Mulls a Policy Change for Cuba

Long-standing public and political contention over the effects of the United States' economic embargo on the health of the Cuban people appears to be approaching a watershed. The proponents of a change in U.S. policy base their arguments on the results of scientific research over recent years that indicate the embargo has contributed to unhealthy shortages of food and medicine in Cuba. In both houses of Congress, bills are being considered that would exempt from the embargo the sale of food to

Written bySteve Bunk
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

When Pope John Paul II left Cuba on January 25, his departure address at Jose Marti Airport in Havana included a final chastisement of both the Cuban and U.S. governments for their feud of almost four decades. He decried "the suffering caused by material and moral poverty, the roots of which may be found, among other things, in unjust inequalities, in limitations to fundamental freedoms, in depersonalization and the discouragement of individuals, and in oppressive economic measures, unjust and ethically unacceptable, imposed from outside the country." The following month, President Bill Clinton responded to concerns highlighted during the Pope's visit by announcing several "actions" to lessen the burden of the embargo on the Cuban people. Among them was restoration of direct humanitarian charter flights carrying food and medical goods to the island. These flights had been halted in 1996, after Cuban fighter planes in international airspace shot down two civilian ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies